# Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects

> **NCT02312193** · — · COMPLETED · sponsor: **Neuromed IRCCS** · enrollment: 95 (estimated)

## Conditions studied

- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02312193
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2022-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312193, "Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02312193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*